He thought that $18.02 was the ACTUAL cose on 12/31 - not the dividend-adjusted close as he mentioned the dividend in a manner to suggest that the ostensible drop in the stock from $18.19 to the current price was partly due to the dividend.
how about a little attention to detail out of you once in a while? Pfizer absolutely did NOT close at $18.02 at year-end 2009 - the close was $18.19.
In going from $18.19 to Friday's $16.91, a decline of 7%, it would up #28 for the year in the Dow 30 and underperformed the average Dow stock by ten full percentage points.
Pfizer is NOT a stock that underperforming fund managers trying to stem withdrawals would want to show on their stock list at quarter end.
Yes - contrary to what you might think, underperforming fund managers absolutely want to dump stocks that underperform by double digits. And that's just what is happening. As the quarter draws to a close, PFE is underperforming the likes of BMY.
And yet if you just look at the fundamentals, there's absolutely NO reason besides momentum and window-dressing to prefer BMY. Its Price to Expected Free Cash Flow ratio for 2013 is 14.2 compared with just 6.7 for Pfizer.
What an absolute JOKE!
You may be OK when it comes to law but when it comes to either numbers or logic, you're a complete washout. I don't know why you even bother trying to fake it anymore.